Survival Advantage of Radiofrequency Ablation Over Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Good Performance Status Within the Milan Criteria
Crossref DOI link: https://doi.org/10.1245/s10434-014-3831-2
Published Online: 2014-06-06
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Po-Hong
Lee, Yun-Hsuan
Hsu, Chia-Yang
Huang, Yi-Hsiang
Chiou, Yi-You
Lin, Han-Chieh
Huo, Teh-Ia
Text and Data Mining valid from 2014-06-06